Polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market comprises of sales of PCR, real time PCR testing services & related products. Polymerase chain reaction (PCR) & Real time Polymerase chain reaction (PCR) testing establishments construct, develop/deploy the related devices, reagents & services, to detect or measure the DNA (or RNA) in a sample. It finds its applications in mutation testing, cloning, genotyping, sequencing, paternity testing, and microarrays.
Early detection plays a vital role
in treating Covid-19 patients. Real time RT-PCR technique is an extremely
sensitive & specific testing method that can deliver the reliable diagnosis
in as fast as three hours. Real time RT-PCR is considerably faster and has a lower
potential for contamination as the entire process is within the closed tube.
Hence, it is considered to be the most precise method available for detection
of the corona-virus or Covid-19. This has created massive demand for PCR
testing kits.
According to study, “Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) Testing Global Market Report 2020-30: Covid 19 Implications and Growth” the key companies operating in the global Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) market are Biomerieux Sa, Bio-Rad Laboratories, Abbott Laboratories, Agilent Technologies Inc., F.Hoffmann-La Roche Ltd (Roche Diagnostics), Thermo Fisher Scientific, Inc., Qiagen N.V., Genmark Diagnostics, General Electric Company (Ge Healthcare), Luminex Corporation, Danaher, Becton Dickinson And Company, Meridian Bioscience.
Based on offering, Polymerase Chain
Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) market is
segregated as assay, instruments, panels & consumables, reagents,
accessories and software. Based on
application, market is segregated as microRNA analysis, virus & bacterial
analysis, fish species detection and microplasma species detection. In
addition, based on end-user, market is segregated as pharmaceuticals,
healthcare, agriculture and others.
The Polymerase Chain Reaction (PCR)
And Real-time Polymerase Chain Reaction (PCR)
market is driven by increase in population base for chronic disease
patients, followed by growth in technological advancements in the field of life
science, rise in incidence of infectious disease & genetic disorders and
increase in public-private funds, investments, and grants for PCR-based
research. However, high cost of PCR instruments and development of alternative
technologies may impact the market. Moreover, rise in shift from plant-derived
to genome-based drug discovery and increase in market penetration in emerging
countries is key opportunities for market.
Based on geography, the
North-American region dominates the global Polymerase Chain Reaction (PCR) And
Real-time Polymerase Chain Reaction (PCR) market owing to strong presence of
major PCR manufacturers and rise in demand for rapid diagnostic tests in the
region. The Asian-Pacific and North-American regions are estimated to witness
higher growth rate due to increase in the patient pool due to occurrence of
chronic & infectious diseases over the forecast period. It is predicted
that future of the global market will be bright as a result of expansion of its
application areas coupled with increase is accuracy & precision during the
forecast period. It is also predicted that the global Polymerase Chain Reaction
(PCR) And Real-time Polymerase Chain Reaction (PCR) market will be reached at
US $10.1 billion by 2023, at a CAGR of 7.9%.
For More Information, Click on the Link Below:-
Global
Polymerase Chain Reaction (PCR) and Real-time Polymerase Chain Reaction (PCR) Market
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing &
Communications
No comments:
Post a Comment